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Introduction: Breast cancer is the most cofilmon malignancy and the most
common cancer in women. During the last decade, biological markers of breast
cancer have attracted many researchers that can be used alone or in combination to
predict the degree of histology, the behavior of the tumor and its invasive nature.
In case of finding the relationship between the clinical stage of the tumor and the
serum biomarkers and considering the cost-effectiveness, availability and non-
invasiveness, they can be used as independent factors in predicting tumor behavior
and their degree of invasiveness and the type of treatment planning.
Materials and MethodS3 The study population includes patients with
breast cancer whose information was available at the Pathology and Stem Cell
Research Center. The required information was collected and analyzedthrough
patient files. After removing patients with incomplete variables, samples whose
serum Ca15-3 levels were available were included in the study. The variables
studied included age, ER, PR" Her2 and degree of grading and staging of the
tumor. Datawere collected and analyzed using statistical methods.
Resultsl The results of our study on 20 patients indicate that the highest level oI
Cal53 is present in Grade 2 and Stage 3, but there is no statistically significant
relationship between its serum level and stage or tumor grade. No significant
association was found between serum Cal5-3 levels and other tissue tumor
markers.
Conclusion: This study shows that the sentm level of the tumor marker cal5-3
is higher in stage 3 and grade 2. Although this difference was not statistically
significant, it is possible that these results indicate that there is ca153 in the
primary tumor, but in the initial site due to lack of systemic circulation and low
growth of the tumor, the marker can not be detected. And has sought to invade md
grow tumor marker into the systemic bloodstream. As a result, it is recommended
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